Synektik Spólka Akcyjna Share Price

Equities

SNT

PLSNKTK00019

Advanced Medical Equipment & Technology

Market Closed - Warsaw S.E. 09:25:56 31/05/2024 pm IST 5-day change 1st Jan Change
140 PLN -2.10% Intraday chart for Synektik Spólka Akcyjna -1.13% +62.79%

Financials

Sales 2024 * 518M 132M 10.98B Sales 2025 * 521M 132M 11.04B Capitalization 1.19B 303M 25.31B
Net income 2024 * 73M 18.55M 1.55B Net income 2025 * 64M 16.27M 1.36B EV / Sales 2024 * 2.15 x
Net cash position 2024 * 78.68M 20M 1.67B Net cash position 2025 * 88.79M 22.57M 1.88B EV / Sales 2025 * 2.12 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
15.4 x
Employees 165
Yield 2024 *
2.45%
Yield 2025 *
2.01%
Free-Float 49.86%
More Fundamentals * Assessed data
Dynamic Chart
Synektik with Climamedic signs System Supply Agreement Worth PLN 17.7 Million Net with Hospital in Warsaw CI
Synektik Announces Dividend for the Financial Year Ended on September 30, 2023, Payable on March 8, 2024 CI
Synektik Spólka Akcyjna Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Synektik Signs EUR 3.7 Million Contract for Delivery of Da Vinci CI
Synektik Spólka Akcyjna Signs PLN 21.7 Million Contract with Hospital in Bydgoszcz CI
Synektik Spólka Akcyjna Signs PLN 11.7 Million Contract with Hospital in Wroclaw CI
Synektik Signs PLN 13.9 Million Contract with Hospital in Szczecin CI
Synektik Spólka Akcyjna Signs PLN 13.3 Million Contract with Bialystok Oncology Centre CI
Synektik Spólka Akcyjna Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Synektik Spólka Akcyjna Reports Earnings Results for the Fourth Quarter Ended September 30, 2023 CI
Synektik Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Synektik Spólka Akcyjna Reports Earnings Results for the Half Year Ended March 31, 2023 CI
Synektik Spólka Akcyjna Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
Synektik Spólka Akcyjna Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Synektik Spólka Akcyjna Reports Earnings Results for the Fourth Quarter Ended September 30, 2022 CI
More news
1 day-2.10%
1 week-1.13%
1 month+8.36%
3 months+6.46%
6 months+74.13%
Current year+62.79%
More quotes
1 week
139.00
Extreme 139
149.80
1 month
126.20
Extreme 126.2
151.00
Current year
80.80
Extreme 80.8
157.00
1 year
54.60
Extreme 54.6
157.00
3 years
22.50
Extreme 22.5
157.00
5 years
10.20
Extreme 10.2
157.00
10 years
8.56
Extreme 8.56
157.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 04/01/04
Founder - 04/01/04
Director/Board Member - 11/11/11
Members of the board TitleAgeSince
Chairman 52 10/18/10
Director/Board Member 58 16/17/16
Director/Board Member 61 -
More insiders
Date Price Change Volume
31/24/31 140 -2.10% 19,462
29/24/29 143 -4.54% 28,882
28/24/28 149.8 +2.18% 25,966
27/24/27 146.6 +3.53% 32,228

Delayed Quote Warsaw S.E., May 31, 2024 at 09:25 pm IST

More quotes
Synektik SA is a Poland-based company active in the medical sector. It produces PACS software which allows running a diagnostic imaging laboratory. It runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The Company sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
140 PLN
Average target price
135.3 PLN
Spread / Average Target
-3.33%
Consensus

Quarterly revenue - Rate of surprise